Skip to main content
logo
Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
97.00
-0.20 (-0.21%)
Mar 24, 2026, 12:23 PM AST

TADAWUL:4016 Ratios and Metrics

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,9442,2242,436---
Market Cap Growth
-28.21%-8.70%----
Enterprise Value
1,9732,2672,496---
Last Close Price
97.20111.20119.61---
PE Ratio
20.0422.9330.51---
Forward PE
16.3120.1624.86---
PS Ratio
4.224.836.18---
PB Ratio
4.675.346.62---
P/TBV Ratio
5.496.297.67---
P/FCF Ratio
26.3630.16111.20---
P/OCF Ratio
21.9625.1273.65---
EV/Sales Ratio
4.294.926.33---
EV/EBITDA Ratio
16.5619.0325.19---
EV/EBIT Ratio
18.4621.2027.95---
EV/FCF Ratio
26.7630.74113.93---
Debt / Equity Ratio
0.150.150.170.200.300.33
Debt / EBITDA Ratio
0.540.540.640.731.111.05
Debt / FCF Ratio
0.870.872.890.861.443.44
Net Debt / Equity Ratio
0.070.070.110.150.220.26
Net Debt / EBITDA Ratio
0.250.250.410.550.800.82
Net Debt / FCF Ratio
0.400.401.850.651.042.69
Asset Turnover
0.820.820.800.760.700.73
Inventory Turnover
1.771.771.681.441.371.45
Quick Ratio
2.242.241.851.491.361.59
Current Ratio
3.133.132.652.362.222.30
Return on Equity (ROE)
24.73%24.73%23.67%22.44%21.72%25.52%
Return on Assets (ROA)
11.87%11.87%11.39%10.83%10.10%12.09%
Return on Invested Capital (ROIC)
23.25%23.40%21.67%20.57%18.76%22.59%
Return on Capital Employed (ROCE)
22.90%22.90%22.70%23.40%22.30%25.40%
Earnings Yield
4.99%4.36%3.28%---
FCF Yield
3.79%3.32%0.90%---
Dividend Yield
2.57%-1.67%---
Payout Ratio
48.43%48.43%18.79%54.69%61.14%56.12%
Total Shareholder Return
2.57%-1.67%---
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.